Updates on Advanced Breast Cancer: Local Management and Other New Perspectives

---

LIVEBreast OncologySurgeryBreast Medical OncologyGeneral Surgery Oncology

Thursday, February 25, 2027, 12:30 PM - Friday, February 26, 2027, 5:30 PM, Marriott Medical Center Hotel Houston, Houston, TX


AMA PRA Category 1 Credits™ (11.00 hours), AAPA Category 1 CME (11.00 hours), ABIM MOC Part 2 (11.00 hours), ABS CC SAM (11.00 hours), ACPE Contact Hour(s) (11.00 hours), ANCC - Nursing Contact Hour(s) (11.00 hours), Non-Physician Attendance (11.00 hours), Pharmacotherapeutics (0.00 hours), SW - Social Work (3.00 hours)

Stay current with emerging advances in the management of advanced breast cancer at this comprehensive educational conference. The 2027 program will highlight evolving approaches to local and systemic management, including precision medicine strategies, antibody-drug conjugates, novel targeted therapies, immunotherapy, cellular therapies, and the integration of liquid biopsy technologies such as circulating tumor DNA (ctDNA) and measurable residual disease (MRD) monitoring. Faculty will discuss advances in biomarker-driven treatment selection, multiomic profiling, artificial intelligence and machine learning applications, management of CNS disease, survivorship considerations, and supportive care interventions designed to optimize patient outcomes. The conference will also examine new perspectives in multidisciplinary breast cancer care, emphasizing collaboration among medical oncologists, surgeons, advanced practice providers, nurse navigators, pharmacists, social workers, patient advocates, and other members of the healthcare team. Through expert presentations, case-based discussions, panel discussions, and practical clinical insights, participants will gain strategies to personalize treatment plans, manage treatment related toxicities, evaluate clinical trial opportunities, incorporate emerging technologies into clinical practice, and apply evidence-based approaches to improve outcomes for patients living with advanced breast cancer.

1. Evaluate emerging systemic therapies, including targeted therapies, immunotherapies, and cellular therapies, for patients with advanced breast cancer.
2. Incorporate biomarker, liquid biopsy, and multiomic data into clinical decision-making to support personalized treatment strategies for patients with advanced breast cancer.
3. Identify and manage treatment-related toxicities and supportive care needs associated with novel and established therapies used in advanced breast cancer care.
4. Assess current and emerging approaches to local and systemic management, including strategies for patients with CNS involvement and other complex clinical challenges.
5. Apply multidisciplinary and patient-centered approaches, including advances in diagnostics, clinical trials, and emerging technologies, to improve outcomes for patients with advanced breast cancer.

Join us for Updates on Advanced Breast Cancer: Local Management and New Perspectives, a one-and-a-half-day educational program featuring a half-day pre-conference workshop program followed by a full-day conference. The meeting will be held at the Houston Marriott Medical Center (6580 Fannin Street, Houston, Texas 77030).

• Thursday, February 25, 2027
  Day 1 – Pre-Conference Workshops. Welcome and workshop overview begin at 1:00 PM, with workshops concluding at 5:00 PM.

  • Workshop 1: (1:05 PM - 2:55 PM)

    Cell Therapy in Breast Cancer and Beyond

  • Workshop 2: (3:10 PM - 5:00 PM)

    Layering Multiomic Information Into Prognostication and Stratification in Breast Cancer and Beyond

• Friday, February 26, 2027
  The conference begins at 8:00 AM with Welcome and Opening Remarks and concludes at 5:00 PM. A Welcome Reception and Networking Event will follow from 5:00 PM – 6:00 PM.

Advanced registration is encouraged as space is limited. If you are considering attending this conference, please follow the link below to create a profile in PEP prior to registering: https://mdanderson.cloud-cme.com/default.aspx

The deadline for advanced registration Monday, Jan. 25, 2027. 

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)

• Check made payable to: The University of Texas MD Anderson Cancer Center (payable through U.S. banks only)

Mail to: 

      Continuing Professional Education – Unit 1781
       The University of Texas MD Anderson Cancer Center
       P.O. Box 301407
       Houston, Texas 77230-1407

Telephone registrations are not accepted

When registering online a receipt (confirmation) will be automatically emailed to the e-mail address you list on the registration form.

Refund/Cancellation Policy: The registration fee, minus a $15.00 administration-handling fee, is refundable if a written request is received on or before Monday, Jan. 25, 2027.  No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. The Department of Continuing Professional Education (CPE) reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of CPE, is limited to the registration fee.  CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

For additional information, contact CPE, at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

Special Assistance Contact CPE, at 713-792-2223 or toll free at 866-849-5866 if you have any ADA accommodation needs.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Texas MD Anderson Cancer Center designates this live activity will award 11.00 Nursing Contact Hour(s) which includes APRN 9.25 Pharmacotherapeutics credit(s)

AMERICAN BOARD OF INTERNAL MEDICINE (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf.  In order to receive MOC points, you must pass the post-test with a score of 70% or higher. 

The University of Texas MD Anderson Cancer Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 11.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

The University of Texas MD Anderson Cancer Center designates this application-based activity for 11.00hours under UAN JA000####-###-####-##. Credits will be provided to NABP CPE Monitor within 60 days after the activity completion. Learners must provide their NABP e-profile ID and Date of Birth in their MyCE Profile for credits to be reported to CPE Monitor.

The University of Texas MD Anderson (CEU Provider #4607) is an approved continuing education provider for Social Workers through the Texas State Board of Social Worker Examiners. This activity has been approved for 3.0 continuing education units.

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 

Hotel Accommodations

Houston Marriott Medical Center/Museum District Hotel
6580 Fannin Street
Houston, TX 77030
Phone: (713) 796-0080

Group Rate: $215 per night (plus taxes)

Reservation Deadline: Thursday, February 4, 2027

Book your group rate for 2027 Advanced Breast Cancer Conference

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the educational content of a certified continuing education (CE) activity, including faculty, planners, reviewers, are required to disclose all financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used on or by patients. All relevant financial relationships have been mitigated prior to the start of the activity.

Exhibitor Registration Requirements

• Registration & Agreement: To participate as an exhibitor, both registration and a signed exhibit agreement are required.

• Confirmation Process: Your exhibit is only confirmed after completing registration and submitting a fully executed agreement.

• Payment Timeline: The signed agreement and payment must be submitted prior to the event.

• Additional Badges: Extra exhibitor badges can only be purchased by companies with confirmed exhibitor status.

• Support Clarification: Grant and in-kind support are independent and separate from exhibitor fees.

W9 Form